Clearwater International France advised the shareholders of C2S on the disposal of the Group to Eurazeo Patrimoine, the Eurazeo division specialised in investments in tangible assets.
The C2S Group is the 8th largest private clinic operator in France and a regional leader in Auvergne, Rhône-Alpes and Burgundy Franche-Comté. It operates 11 clinics, primarily specialising in short and medium-length stays in general medicine, surgery and follow-up care. It also owns the buildings for seven of its clinics. The group has 500 medical practitioners, who participate in the group’s governance and nearly 1,800 employees. In 2016, it treated over 235,000 patients (75% as outpatients) and reported revenues of €158 million.
With the support of its majority shareholder, the Group successively acquired a private clinic in Ambérieu (HPA) in 2015 and Groupe Avenir Santé in 2016, before selling the Polyclinique de Bordeaux-Tondu in 2017. These successive operations enabled C2S to strengthen its presence in the Rhône-Alpes and Burgundy regions.
Following a competitive process gathering French and international industrial and PE players, Eurazeo Patrimoine’s offer was retained by the sellers, supported by a bank pool identified by Clearwater’s Debt Advisory team.
The Clearwater International France team, composed of Philippe Guézenec, Managing Partner, Benjamin Zayat, Managing Partner, Aubert Simonnot, Associate Director, Guillaume Fenni, Analyst, and Laurence de Rosamel, Director (Debt Advisory), Paul Assaël, Associate (Debt Advisory) and Léa Joly, Analyst (Debt Advisory) advised C2S shareholders in this transaction.